TFAP2C Attenuates Hypertensive Endothelial Dysfunction by Transcriptionally Activating SPRY4 : A Novel Axis Regulated by miR ‐3656

To investigate the role of transcription factor AP-2γ (TFAP2C) in hypertensive endothelial dysfunction and elucidate the regulatory mechanism of the miR-3656/TFAP2C/SPRY4 signaling axis. Plasma TFAP2C levels were measured by ELISA in 91 hypertensive patients and 101 healthy controls. Human umbilical vein endothelial cells (HUVECs) and human aortic endothelial cells (HAECs) were subjected to TFAP2C overexpression or knockdown, followed by assessment of cell proliferation, migration, apoptosis, and tube formation. Bioinformatics prediction, ChIP-qPCR, dual-luciferase reporter assay, RT-qPCR, and western blot were used to identify Sprouty4 (SPRY4) as a direct transcriptional target of TFAP2C. Rescue experiments confirmed the mediating role of SPRY4 and the hierarchical relationship of the miR-3656/TFAP2C/SPRY4 axis. TFAP2C levels were significantly lower in hypertensive patients than in healthy controls (7.40 ± 6.28 vs. 10.04 ± 5.90, p = 0.003) and correlated negatively with blood pressure. TFAP2C overexpression significantly enhanced endothelial proliferation, migration, and tube formation while inhibiting apoptosis, whereas TFAP2C knockdown produced the opposite effects (p < 0.05). SPRY4 was identified as a direct transcriptional target of TFAP2C. Rescue experiments demonstrated that SPRY4 overexpression partially reversed TFAP2C knockdown-induced endothelial dysfunction. Furthermore, miR-3656 negatively regulated the TFAP2C/SPRY4 axis, and SPRY4 overexpression alleviated miR-3656-induced impairment of endothelial function. TFAP2C is downregulated in hypertensive patients and exerts protective effects against endothelial dysfunction by transcriptionally activating SPRY4. The miR-3656/TFAP2C/SPRY4 axis represents a novel regulatory cascade in endothelial dysfunction. TFAP2C may serve as a potential circulating marker associated with endothelial dysfunction in hypertension.

Authors

Institutions

Publication Details

Journal
The FASEB Journal
Published
2026-11-13
DOI
https://doi.org/10.1096/fj.202603091rr
Primary Topic
MicroRNA in disease regulation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

TFAP2C Attenuates Hypertensive Endothelial Dysfunction by Transcriptionally Activating SPRY4 : A Novel Axis Regulated by miR ‐3656

樊鑫鑫, Yaxuan Ren, Yi Cheng, Yu Tian et al.
2 links
The FASEB Journal
MicroRNA in disease regulation
article

TFAP2C Attenuates Hypertensive Endothelial Dysfunction by Transcriptionally Activating SPRY4 : A Novel Axis Regulated by miR ‐3656

樊鑫鑫, Yaxuan Ren, Yi Cheng, Yu Tian, Junbo Zhan, Yawen Liu, Xinmeng Hu
article en

Abstract

To investigate the role of transcription factor AP-2γ (TFAP2C) in hypertensive endothelial dysfunction and elucidate the regulatory mechanism of the miR-3656/TFAP2C/SPRY4 signaling axis. Plasma TFAP2C levels were measured by ELISA in 91 hypertensive patients and 101 healthy controls. Human umbilical vein endothelial cells (HUVECs) and human aortic endothelial cells (HAECs) were subjected to TFAP2C overexpression or knockdown, followed by assessment of cell proliferation, migration, apoptosis, and tube formation. Bioinformatics prediction, ChIP-qPCR, dual-luciferase reporter assay, RT-qPCR, and western blot were used to identify Sprouty4 (SPRY4) as a direct transcriptional target of TFAP2C. Rescue experiments confirmed the mediating role of SPRY4 and the hierarchical relationship of the miR-3656/TFAP2C/SPRY4 axis. TFAP2C levels were significantly lower in hypertensive patients than in healthy controls (7.40 ± 6.28 vs. 10.04 ± 5.90, p = 0.003) and correlated negatively with blood pressure. TFAP2C overexpression significantly enhanced endothelial proliferation, migration, and tube formation while inhibiting apoptosis, whereas TFAP2C knockdown produced the opposite effects (p < 0.05). SPRY4 was identified as a direct transcriptional target of TFAP2C. Rescue experiments demonstrated that SPRY4 overexpression partially reversed TFAP2C knockdown-induced endothelial dysfunction. Furthermore, miR-3656 negatively regulated the TFAP2C/SPRY4 axis, and SPRY4 overexpression alleviated miR-3656-induced impairment of endothelial function. TFAP2C is downregulated in hypertensive patients and exerts protective effects against endothelial dysfunction by transcriptionally activating SPRY4. The miR-3656/TFAP2C/SPRY4 axis represents a novel regulatory cascade in endothelial dysfunction. TFAP2C may serve as a potential circulating marker associated with endothelial dysfunction in hypertension.

The FASEB JournalVol. 40(22)
Hunan Normal University (CN), Jilin University (CN), First Hospital of Jilin University (CN)
National Natural Science Foundation of China, Hunan Normal University
Good health and well-being
MicroRNA in disease regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon